씨유메디칼

115480KOSDAQ

64.3 / 100

Reference Date: 2026-09-08

Financial Score18.0 / 40

News Sentiment21.3 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but PER raises overvaluation concerns. Surged 30.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

CY Medikal focuses on emergency medical devices (AEDs) and surgical robotics, leveraging global AED market growth and partnerships with Chinese robotics firms to diversify revenue. In 2024, AEDs accounted for 86.2% of sales, with overseas expansion driven by subsidiaries in Germany and Japan.

Number of Employees

113people

Average Salary

52.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

175.00Industry Average 15.000.0Point

11.7x industry avg (risky)

PBR

0.50Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

1.38Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

50.76Industry Average 100.005.0Point

Lower than industry avg (good)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲48.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -6.2% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
씨유메디칼, 캐논 日 자회사와 협력… 아시안게임에 제품 공급
씨유메디칼의 AED 'CU-SPR'이 일본 시장 확대 및 아시안게임 공급 확대로 긍정적인 시장 반응을 얻고 있다.
Positive
비스토스, 자사주 매입 이어 생산시설 확장…"하반기 본격 실적 반등.....
비스토스의 자사주 매입과 생산시설 확장으로 하반기 실적 개선 기대감이 높아짐.
Positive
씨유메디칼, 올 상반기 영업이익 99억… 전년比 181% 증가
씨유메디칼의 상반기 영업이익이 전년 대비 181% 증가하며 실적 개선을 보여주었다.

Detailed Momentum

52-week position8.0Point

Near 52w high (100%, uptrend)

Current 2,450Won52-week high 2,45052-week low 469

1-month return6.0Point

1m +30.67% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral전환가액의조정2026-08-31
Neutral반기보고서 (2026.06)2026-08-14
Neutral주식등의대량보유상황보고서(약식)2026-08-10